Literature DB >> 33160350

Can thyroidectomy be considered safe in obese patients? A retrospective cohort study.

Gian Luigi Canu1, Fabio Medas2, Federico Cappellacci2, Michele Guido Podda2, Giorgio Romano3, Enrico Erdas2, Pietro Giorgio Calò2.   

Abstract

BACKGROUND: Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.
METHODS: Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into two groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B. Univariate analysis was performed to compare these two groups. Moreover, multivariate analyses were performed to evaluate whether the BMI value (considered in this case as a continuous variable) had a significant role in the development of each individual postoperative complication.
RESULTS: A total of 813 patients were included in this study: 31 (3.81%) were underweight, 361 (44.40%) normal-weight, 286 (35.18%) overweight, 94 (11.57%) obese and 41 (5.04%) morbidly obese. Six hundred and seventy-eight patients were included in Group A and 135 in Group B. At univariate analysis, the comparison between the two groups, in terms of operative time and thyroid weight resulted in statistically significant results (P = 0.001, P = 0.008; respectively). These features were significantly higher in Group B than in Group A. About postoperative stay and complications, no statistically significant difference was found between the two groups. At multivariate analyses, only the development of cervical haematoma was statistically significantly correlated to the BMI value. Patients with high BMI had a lower risk of cervical haematoma (P = 0.045, OR 0.797, 95% CI 0.638-0.995).
CONCLUSIONS: This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients. Our result about operative times had no clinical significance.

Entities:  

Keywords:  BMI; Body mass index; Complications; Endocrine surgery; Obesity; Thyroidectomy

Mesh:

Year:  2020        PMID: 33160350      PMCID: PMC7648980          DOI: 10.1186/s12893-020-00939-w

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


Background

Obesity is a growing public health concern in most western countries. The World Health Organization (WHO), in 2016, stated that obesity had nearly tripled since 1975 worldwide with more than 1.9 billion adults overweight, among whom 650 million obese [1]. Elevated body mass index (BMI) represents a major risk factor for several comorbidities, such as diabetes mellitus, musculoskeletal disorders, cardiovascular disease and some types of cancers, including thyroid carcinoma [2-5]. These comorbidities increase medical costs, which can be particularly burdensome considering the overall increase in life expectancy [2]. More and more patients with high BMI are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before [6-9]. For this reason, there is a growing interest in understanding the impact of elevated BMI on surgical outcomes. Obesity is considered by many surgeons, including endocrine surgeons, as a condition associated with worse surgical outcomes and postoperative complications. However, in the literature, substantial controversy exists about a correlation between high BMI and postoperative morbidity and mortality in numerous surgical fields. Some authors, for example, observed that elevated BMI increases morbidity in elective spine surgery and laparoscopic colorectal surgery, while, on the other hand, in a large review of 101,078 patients who underwent emergency abdominal operations, obesity has even been described as protective against mortality [6-8]. About thyroid surgery and obesity, the literature is limited. Moreover, among existing studies, most of them include a limited number of patients, while those with the largest populations do not evaluate recurrent laryngeal nerve (RLN) injury and hypoparathyroidism, which are the two main complications of thyroidectomy [4, 5, 10–18]. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.

Methods

Study design

In this retrospective cohort study we considered patients undergoing thyroidectomy between January 2014 and December 2018 in our Unit of General and Endocrine Surgery (University of Cagliari). Patients were identified from a prospectively maintained institutional database. Only patients who underwent conventional open total thyroidectomy, performed by the two most skilled endocrine surgeons of our Unit, were included. We excluded from this study patients simultaneously submitted to parathyroidectomy, parathyroid autotransplantation or lateral and/or central lymph node dissection and those with incomplete data. BMI values were stratified according to the standardized categories set by the World Health Organization: < 18.5 kg/m2 (underweight), 18.5–24.9 kg/m2 (normal-weight), 25–29.9 kg/m2 (overweight), 30–34.9 kg/m2 (obese), ≥ 35 kg/m2 (morbidly obese) [19]. Enrolled patients were divided into two groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B. Demographic data, BMI, histological findings, surgical outcomes (operative time, postoperative stay) and postoperative complications (hypoparathyroidism, recurrent laryngeal nerve injury, cervical haematoma, wound infection) were analysed.

Endpoints

The primary endpoint was the occurrence of postoperative complications, while secondary endpoints were operative time and postoperative stay.

Surgical procedure

All patients were euthyroid at the time of surgery. Parathyroid glands and recurrent laryngeal nerves were systematically searched and identified. In order to facilitate nerve identification and to confirm its functional integrity, intraoperative nerve monitoring (IONM) was often utilized. Energy-based devices were routinely used to achieve haemostasis. The duration of the operation was estimated from skin incision to skin closure (in minutes).

Postoperative management and classification of complications

Postoperative fibrolaryngoscopy was performed to assess vocal cord mobility in case of suspected recurrent laryngeal nerve injury. Serum calcium and PTH values were assayed pre- and postoperatively. Postsurgical hypoparathyroidism was defined as PTH levels < 10 pg/mL following surgery (normal range = 10–65 pg/mL). In the case of PTH concentrations below the normal range for more than 12 months, hypoparathyroidism was considered permanent. Postoperative complications were categorized according to the Clavien–Dindo classification. Transient and permanent hypoparathyroidism were considered as grade I (requiring electrolyte correction), unilateral recurrent laryngeal nerve injury and wound infection as grade II (needing corticosteroid therapy and antibiotic therapy, respectively), bilateral recurrent laryngeal nerve injury and cervical haematoma as grade IIIb (requiring surgical treatment under general anesthesia, tracheostomy and surgical revision of hemostasis, respectively).

Statistical analysis

Statistical analyses were performed with MedCalc® 19.1.3. In univariate analysis, Fisher exact test or Chi-squared test were used for categorical variables and t-test for continuous variables. Multivariate analyses were performed to evaluate whether the BMI value (considered in this case as a continuous variable) had a significant role in the development of postoperative complications. For this purpose, a multivariate analysis was conducted for each individual complication (transient hypoparathyroidism, permanent hypoparathyroidism, cervical haematoma, unilateral RLN injury, bilateral RLN injury and wound infection), considering as independent variables, other than BMI, sex, age, operative time, thyroid weight and histological diagnosis. The results regarding the influence of BMI on postoperative complications were extrapolated from each multivariate analysis and represented in a single forest plot. The difference in terms of operative times between the two groups examined was represented through a box plot. P values < 0.05 were considered statistically significant.

Results

A total of 1594 consecutive patients were submitted to thyroidectomy within the period analysed. Eight hundred and thirteen met the inclusion criteria: 31 (3.81%) were underweight, 361 (44.40%) normal-weight, 286 (35.18%) overweight, 94 (11.57%) obese and 41 (5.04%) morbidly obese. Six hundred and seventy-eight patients were included in Group A and 135 in Group B. Age, sex and histopathological findings were comparable between the two groups, while the mean BMI was significantly higher in Group B than in Group A (34.04 ± 4.02 vs 24.03 ± 3.25, P < 0.001). These results are shown in Table 1, while in Table 2 are reported surgical outcomes and postoperative complications.
Table 1

Demographic data, BMI and histopathological findings

Total(n = 813)Group A(n = 678)Group B(n = 135)P value
Sex
 Male238 (29.27%)198 (29.20%)40 (29.63%)0.921
 Female575 (70.73%)480 (70.80%)95 (70.37%)
Age (years, mean ± SD)54.36 ± 14.1153.99 ± 14.1156.21 ± 14.010.094
BMI (kg/m2, mean ± SD)25.69 ± 5.0324.03 ± 3.2534.04 ± 4.02 < 0.001
Thyroid weight (g, mean ± SD)46.9 ± 51.4144.77 ± 44.8957.57 ± 75.490.008
Histological diagnosis
 Benign disease506 (62.24%)418 (61.65%)88 (65.19%)0.439
 Malignancy307 (37.76%)260 (38.35%)47 (34.81%)

Statistically significant values are shown in bold

SD standard deviation, BMI body mass index

Table 2

Surgical outcomes and complications

Total(n = 813)Group A(n = 678)Group B(n = 135)P value
Operative time (minutes, mean ± SD)87.66 ± 19.6086.63 ± 19.2092.81 ± 20.810.001
Postoperative stay (days, mean ± SD)2.98 ± 1.532.94 ± 1.593.16 ± 1.190.123
Transient hypoparathyroidism172 (21.16%)147 (21.68%)25 (18.52%)0.411
Permanent hypoparathyroidism48 (5.90%)37 (5.46%)11 (8.15%)0.226
Cervical haematoma9 (1.11%)9 (1.33%)00.369
Unilateral recurrent nerve injury22 (2.71%)19 (2.80%)3 (2.22%)1.000
Bilateral recurrent nerve injury3 (0.37%)3 (0.44%)01.000
Wound infection2 (0.25%)2 (0.29%)01.000

Statistically significant values are shown in bold

SD standard deviation

Demographic data, BMI and histopathological findings Statistically significant values are shown in bold SD standard deviation, BMI body mass index Surgical outcomes and complications Statistically significant values are shown in bold SD standard deviation In Group A, the mean operative time was 86.63 ± 19.20 min and the mean postoperative stay was 2.94 ± 1.59 days. There were 19 (2.80%) unilateral recurrent laryngeal nerve lesions, 3 (0.44%) bilateral recurrent laryngeal nerve lesions, 9 (1.33%) cervical haematomas, 2 (0.29%) wound infections, 147 (21.68%) cases of transient hypoparathyroidism and 37 (5.46%) cases of permanent hypoparathyroidism. In Group B, the mean operative time was 92.81 ± 20.81 min and the mean postoperative stay was 3.16 ± 1.19 days. There were 3 (2.22%) unilateral recurrent laryngeal nerve lesions, 25 (18.52%) cases of transient hypoparathyroidism and 11 (8.15%) cases of permanent hypoparathyroidism. No bilateral recurrent laryngeal nerve injury, cervical haematoma or wound infection occurred in this group. According to the Clavien-Dindo classification, considering the whole sample, 211 (25.95%) patients were in grade I, 24 (2.95%) in grade II and 12 (1.48%) in grade IIIb. Among patients in Group A, 176 (25.96%) were in grade I, 21 (3.10%) in grade II and 12 (1.77%) in grade IIIb. Among patients in Group B, 35 (25.93%) were in grade I and 3 (2.22%) in grade II. At univariate analysis, the comparison between the two groups, in terms of operative time and thyroid weight resulted in statistically significant results (P = 0.001, P = 0.008; respectively). These features were significantly higher in Group B than in Group A. The difference in operative times between the two groups was represented through a box plot in Fig. 1.
Fig. 1

Box plot representing the difference in terms of operative times between the two groups

Box plot representing the difference in terms of operative times between the two groups Differently, about postoperative stay and complications, no statistically significant difference was found between the two groups. At multivariate analyses, only the development of cervical haematoma was statistically significantly correlated to the BMI value. As shown in Fig. 2, patients with high BMI had a lower risk of cervical haematoma (P = 0.045, OR 0.797, 95% CI 0.638–0.995).
Fig. 2

Forest plot representing the impact of BMI on the development of each individual postoperative complication

Forest plot representing the impact of BMI on the development of each individual postoperative complication

Discussion

Thyroidectomy is the most performed operation in endocrine surgery. It is widely utilized for the treatment of both benign and malignant thyroid diseases. Over 34,000 operations were performed in Italy during 2016 [20]. Although mortality due to this surgical procedure is negligible, morbidity remains a challenging problem, even in the most experienced hands. In this kind of surgery, morbidity is mainly represented by recurrent laryngeal nerve injury, hypoparathyroidism and cervical haematoma [21-25]. The correct positioning of the patient is considered fundamental to achieve the best exposure of the surgical site and therefore the best outcomes. It consists in hyperextension of the neck, which can be obtained through the interposition of a support between the operating table and patient’s shoulders. The wide and short neck of obese patients causes limited hyperextension, which results in a restricted operating field and, therefore, greater difficulty for the surgeon. It is precisely for this reason that many endocrine surgeons consider obese patients at greater risk of postoperative complications. The aim of our study was to evaluate whether postoperative morbidity in obese patients undergoing thyroidectomy is really increased. In order to obtain a homogeneous sample and limit bias, only patients undergoing conventional open thyroidectomy alone were included in this work, while those submitted to minimally invasive video-assisted thyroidectomy (MIVAT) or who simultaneously underwent lateral and/or central neck dissection were excluded. Moreover, for the same purpose, only operations performed by the two most skilled endocrine surgeons of our Unit, with the same competence and experience in the field of thyroid surgery, were considered. Also in our experience, as widely described in the literature, postoperative complications were not increased in obese patients. Furthermore, multivariate analyses even documented a lower risk of cervical haematoma in patients with high BMI. As regards Clavien–Dindo classification, no patient was in grades IV and V. Moreover, it is important to note that no obese patient was in grade III. About the postoperative stay, no statistically significant difference was found between the two groups. As regards our result in terms of operative times, it was certainly influenced, at least in part, by the greater mean weight, and therefore size, of the thyroid gland in the group of obese patients. This difference in size may be due to a delayed diagnosis of thyroid disease in patients with elevated BMI, in whom cervical swellings deriving from thyroid nodules are more difficult to notice because of the high neck circumference. However, it is important to underline that, as in other studies, longer operative times had no clinical significance. Most of the studies conducted so far on the correlation between elevated BMI and postoperative morbidity in the field of thyroid surgery confirm our findings [4, 10–13, 15]. Only three studies documented an increased occurrence of complications [5, 16, 17]. Buerba et al., who examined 18,825 patients undergoing thyroid surgery between 2005 and 2008, found that obese and morbidly obese patients had an increased risk of having at least one complication, especially wound complications. Moreover, they observed that morbid obesity was an independent predictor for urinary complications. However, it is important to underline that, in this study were not evaluated RLN injury and hypoparathyroidism, which are the two main complications of thyroidectomy [17]. Trésallet et al., analysing 1216 patients undergoing thyroidectomy for papillary thyroid carcinoma, observed no difference in terms of overall postoperative complications (including RLN injury, hypocalcaemia, bleeding requiring an emergency operative evacuation, abscess). However, they found that the risk of permanent complications, specifically RLN lesions, were greater in obese patients [5]. Jin et al. retrospectively reviewed 386 patients with papillary thyroid cancer who underwent total thyroidectomy and lateral neck dissection finding an increased occurrence of postoperative haematoma and wound infection in obese patients [16]. As regards operative times, as in our experience, an increase in patients with high BMI has generally been described [10, 12–14, 16, 17]. About the postoperative stay, only one study, conducted by Harari et al. on 443 patients undergoing thyroidectomy for papillary thyroid carcinoma, described an increase in patients with elevated BMI [4]. Our study has two main limitations. First of all, it is based on a retrospective analysis. The second limitation consists in the limited number of obese patients examined in relation to the low occurrence of some complications following thyroidectomy, specifically recurrent laryngeal nerve injury, cervical haematoma and wound infection. This last condition strongly hinders the achievement of a statistical power suitable for an accurate evaluation of these operative complications.

Conclusion

This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients. Our result on operative times, certainly influenced, at least in part, by the greater mean size of the thyroid gland in patients with high BMI, had no clinical significance. Future studies with larger populations, possibly multicenter, and meta-analyses are needed to better investigate this topic.
  22 in total

Review 1.  Prevention and management of bleeding in thyroid surgery.

Authors:  Gabriele Materazzi; Carlo Enrico Ambrosini; Lorenzo Fregoli; Luigi De Napoli; Gianluca Frustaci; Valeria Matteucci; Piermarco Papini; Sohail Bakkar; Paolo Miccoli
Journal:  Gland Surg       Date:  2017-10

2.  Impact of body mass index on post-thyroidectomy morbidity.

Authors:  Claire Blanchard; Sahar Bannani; François Pattou; Laurent Brunaud; Antoine Hamy; Niki Christou; Muriel Mathonnet; Marcel Dahan; Jean-Michel Prades; Gérard Landecy; Henri-Pierre Dernis; Fréderic Sebag; Emmanuel Babin; Alain Bizon; Jean-Christophe Lifante; Frank Jegoux; Christelle Volteau; Cécile Caillard; Valery-Pierre Riche; Éric Mirallié
Journal:  Head Neck       Date:  2019-04-19       Impact factor: 3.147

Review 3.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

4.  Risk of advanced papillary thyroid cancer in obese patients.

Authors:  Avital Harari; Brandon Endo; Stacie Nishimoto; Philip H G Ituarte; Michael W Yeh
Journal:  Arch Surg       Date:  2012-09

5.  The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.

Authors:  Christophe Trésallet; Marie Seman; Frédérique Tissier; Camille Buffet; Renato Micelli Lupinacci; Hélène Vuarnesson; Laurence Leenhardt; Fabrice Menegaux
Journal:  Surgery       Date:  2014-05-27       Impact factor: 3.982

6.  Thyroidectomy in patients with a high BMI: a safe surgery?

Authors:  J B Finel; S Mucci; F Branger; A Venara; P Lenaoures; P Rodien; A Hamy
Journal:  Eur J Endocrinol       Date:  2014-07       Impact factor: 6.664

Review 7.  Obesity and thyroid function.

Authors:  Thomas Reinehr
Journal:  Mol Cell Endocrinol       Date:  2009-06-18       Impact factor: 4.102

8.  Thyroid surgery and obesity: Cohort study of surgical outcomes and local specific complications.

Authors:  Mahmoud Farag; Kareem Ibraheem; Meghan E Garstka; Hosam Shalaby; Christopher DuCoin; Mary Killackey; Emad Kandil
Journal:  Am J Surg       Date:  2018-07-24       Impact factor: 2.565

9.  May predictors of difficulty in thyroid surgery increase the incidence of complications? Prospective study with the proposal of a preoperative score.

Authors:  Valerio D'Orazi; Andrea Sacconi; Silvia Trombetta; Menelaos Karpathiotakis; Daniele Pichelli; Enrico Di Lorenzo; Alice Ortensi; Paolo Urciuoli; Marco Biffoni; Andrea Ortensi
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

10.  Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.

Authors:  Emanuele Di Angelantonio; Shilpa Bhupathiraju; David Wormser; Pei Gao; Stephen Kaptoge; Amy Berrington de Gonzalez; Benjamin Cairns; Rachel Huxley; Chandra Jackson; Grace Joshy; Sarah Lewington; JoAnn Manson; Neil Murphy; Alpa Patel; Jonathan Samet; Mark Woodward; Wei Zheng; Maigen Zhou; Narinder Bansal; Aurelio Barricarte; Brian Carter; James Cerhan; George Smith; Xianghua Fang; Oscar Franco; Jane Green; Jim Halsey; Janet Hildebrand; Keum Jung; Rosemary Korda; Dale McLerran; Steven Moore; Linda O'Keeffe; Ellie Paige; Anna Ramond; Gillian Reeves; Betsy Rolland; Carlotta Sacerdote; Naveed Sattar; Eleni Sofianopoulou; June Stevens; Michael Thun; Hirotsugu Ueshima; Ling Yang; Young Yun; Peter Willeit; Emily Banks; Valerie Beral; Zhengming Chen; Susan Gapstur; Marc Gunter; Patricia Hartge; Sun Jee; Tai-Hing Lam; Richard Peto; John Potter; Walter Willett; Simon Thompson; John Danesh; Frank Hu
Journal:  Lancet       Date:  2016-07-13       Impact factor: 79.321

View more
  4 in total

1.  Transaxillary gasless endoscopic hemithyroidectomy versus conventional open hemithyroidectomy: early single-centre experience.

Authors:  K Jasaitis; M Skimelyte; A Maleckas; D Dauksiene; V Krasauskas; A Gulbinas; A Dauksa
Journal:  Updates Surg       Date:  2022-04-30

Review 2.  Morbid Obesity and Thyroid Cancer Rate. A Review of Literature.

Authors:  Stefania Masone; Nunzio Velotti; Silvia Savastano; Emanuele Filice; Rossana Serao; Antonio Vitiello; Giovanna Berardi; Vincenzo Schiavone; Mario Musella
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

Review 3.  The association of obesity with thyroid carcinoma risk.

Authors:  Xiao-Ni Ma; Cheng-Xu Ma; Li-Jie Hou; Song-Bo Fu
Journal:  Cancer Med       Date:  2022-01-15       Impact factor: 4.452

4.  Intraoperative recurrent laryngeal nerve monitoring in unconventional thyroid surgery.

Authors:  Carta Filippo; Marrosu Valeria; Pinto Valeria; Tatti Melania; Mauro Bontempi; Mariani Cinzia; Puxeddu Roberto
Journal:  Clin Case Rep       Date:  2022-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.